Company intelligence / Profile preview
NaNotics
Mill Valley, California, United Statesnanotics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
NaNotics is a preclinical-stage company developing NaNots, injectable subtractive nanoparticles that selectively clear pathogenic soluble targets from blood while sparing membrane-bound forms, with preclinical efficacy reported in cancer and inflammatory disease models and an excellent safety profile to date.
- Therapeutic areas
- OncologyImmunologyPsychiatryGastroenterology
- Modalities
- Nanoparticle
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Mayo Clinic (collaboration on NaNots technology)Mass General Cancer Center (collaboration on NaNots technology)
Beyond the preview
Go deeper on NaNotics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NaNotics.